Pycnogenol® for supporting recovery and mitigating symptoms and long-term consequences resulting from a SARS-CoV2 infection in COVID-19 patients

COVID-19 can have severe, possibly persisting consequences, like endothelial dysfunction, microcirculatory problems, coagulopathy, cytokine storm and capillary leak syndrome. In various clinical studies, Pycnogenol® revealed positive effects relating to conditions that are also present in SARS-CoV2 infections.

Pycnogenol® improves endothelial health and microcirculation, normalizes platelet reactivity and shows anti-inflammatory effects. Therefore, in this review, authors hypothesize possible additional beneficial effects of Pycnogenol® in patients infected with the new coronavirus SARS-CoV2 and those who suffer from abiding health problems, when complemented to the standard treatment also upon the first day of symptoms or infection.

Symptoms of SARS-CoV2 infection and beneficial effects of Pycnogenol®

Weichmann F, Rohdewald P. Projected supportive effects of Pycnogenol® in patients suffering from multi-dimensional health impairments after a SARS-CoV2 infection. Int J Antimicrob Agents. 2020 Oct 9:106191.